Adalimumab successful in sarcoidosis patients with refractory chronic non-infectious uveitis

INTRODUCTION: Adalimumab, a humanized monoclonal antibody targeted against TNF-α, has proved to be successful in the treatment of uveitis. Another anti-TNF-α agent, i.e., infliximab, has been reported of benefit in the treatment of refractory sarcoidosis. The aim of this prospective case series was...

Descripción completa

Detalles Bibliográficos
Autores principales: Erckens, R. J., Mostard, R. L. M., Wijnen, P. A. H. M., Schouten, J. S., Drent, M.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer-Verlag 2011
Materias:
Inflammatory Disorders
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3332360/
https://www.ncbi.nlm.nih.gov/pubmed/22119879
http://dx.doi.org/10.1007/s00417-011-1844-0

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3332360/
https://www.ncbi.nlm.nih.gov/pubmed/22119879
http://dx.doi.org/10.1007/s00417-011-1844-0

Ejemplares similares